Nexara Health — Health Canada Drug Establishment Licence #3-002896

Metformin Hydrochloride — products, DINs, and Canadian availability

This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Metformin Hydrochloride. We track 120 distinct Drug Identification Numbers (DINs) for this molecule, of which 60 are currently in marketed status. Across those registrations there are 31 manufacturers or marketing authorization holders, 2 dosage forms, and 14 distinct strength presentations.

Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Metformin Hydrochloride in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.

Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Metformin Hydrochloride product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.

Dosage forms and strengths recorded for Metformin Hydrochloride

Dosage forms: Tablet, Tablet (Extended-Release). Strengths: 850 MG, 500 MG, 50 MG, 5 MG, 1000 MG, 100 MG, 4.00 MG, 1 MG, 4 MG, 2 MG, 2.00 MG, 150 MG, 2.5 MG, 12.5 MG.

Manufacturers and marketing authorization holders

ACCEL PHARMA INC, ACCORD HEALTHCARE INC, ANGITA PHARMA INC., APOTEX INC, AURO PHARMA INC, AVANSTRA INC, GLAXOSMITHKLINE INC, BAKER CUMMINS INC, BIOMED PHARMA, DOMINION PHARMACAL, ECL PHARMA GROUP LTD, GLENMARK PHARMACEUTICALS CANADA INC., SANOFI-AVENTIS CANADA INC, BAUSCH HEALTH, CANADA INC., STRIDES PHARMA CANADA INC, JANSSEN INC, MARCAN PHARMACEUTICALS INC, JAMP PHARMA CORPORATION, MERCK CANADA INC, BOEHRINGER INGELHEIM (CANADA) LTD LTEE, and others.

Registered products containing Metformin Hydrochloride

DINProductManufacturerStrengthDosage formStatus
02409291ACC-METFORMINACCEL PHARMA INC850 MGTabletCancelled Pre Market
02406020ACH-METFORMINACCORD HEALTHCARE INC500 MGTabletCancelled Pre Market
02406039ACH-METFORMINACCORD HEALTHCARE INC850 MGTabletCancelled Pre Market
02494418AG-METFORMINANGITA PHARMA INC.500 MGTabletMarketed
02494442AG-METFORMINANGITA PHARMA INC.850 MGTabletMarketed
02557711AG-SITAGLIPTIN HYDROCHLORIDE / METFORMINANGITA PHARMA INC.50 MGTabletMarketed
02557738AG-SITAGLIPTIN HYDROCHLORIDE / METFORMINANGITA PHARMA INC.50 MGTabletMarketed
02557746AG-SITAGLIPTIN HYDROCHLORIDE / METFORMINANGITA PHARMA INC.50 MGTabletMarketed
02536153APO-DAPAGLIFLOZIN-METFORMINAPOTEX INC5 MGTabletMarketed
02536161APO-DAPAGLIFLOZIN-METFORMINAPOTEX INC5 MGTabletMarketed
02229785APO-METFORMINAPOTEX INC850 MGTabletDormant
02167786APO-METFORMINAPOTEX INC500 MGTabletDormant
02305062APO-METFORMIN ERAPOTEX INC500 MGTablet (Extended-Release)Marketed
02460653APO-METFORMIN ERAPOTEX INC1000 MGTablet (Extended-Release)Marketed
02509431APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEAPOTEX INC50 MGTabletMarketed
02509423APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEAPOTEX INC50 MGTabletMarketed
02509415APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDEAPOTEX INC50 MGTabletMarketed
02435772APO-SITAGLIPTIN-METFORMINAPOTEX INC50 MGTabletMarketed
02435780APO-SITAGLIPTIN-METFORMINAPOTEX INC50 MGTabletMarketed
02435799APO-SITAGLIPTIN-METFORMINAPOTEX INC50 MGTabletMarketed
02506289APO-SITAGLIPTIN/METFORMIN XRAPOTEX INC50 MGTablet (Extended-Release)Marketed
02506297APO-SITAGLIPTIN/METFORMIN XRAPOTEX INC100 MGTablet (Extended-Release)Marketed
02506270APO-SITAGLIPTIN/METFORMIN XRAPOTEX INC50 MGTablet (Extended-Release)Marketed
02533073AURO-DAPAGLIFLOZIN / METFORMINAURO PHARMA INC5 MGTabletMarketed
02533081AURO-DAPAGLIFLOZIN / METFORMINAURO PHARMA INC5 MGTabletMarketed
02438283AURO-METFORMINAURO PHARMA INC850 MGTabletMarketed
02438275AURO-METFORMINAURO PHARMA INC500 MGTabletMarketed
02547805AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEAURO PHARMA INC50 MGTabletMarketed
02547821AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEAURO PHARMA INC50 MGTabletMarketed
02547813AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDEAURO PHARMA INC50 MGTabletMarketed
02364506AVA-METFORMINAVANSTRA INC500 MGTabletCancelled Post Market
02364514AVA-METFORMINAVANSTRA INC850 MGTabletCancelled Post Market
02248441AVANDAMETGLAXOSMITHKLINE INC4.00 MGTabletCancelled Post Market
02247085AVANDAMETGLAXOSMITHKLINE INC1 MGTabletCancelled Post Market
02247087AVANDAMETGLAXOSMITHKLINE INC4 MGTabletCancelled Post Market
02247086AVANDAMETGLAXOSMITHKLINE INC2 MGTabletCancelled Post Market
02248440AVANDAMETGLAXOSMITHKLINE INC2.00 MGTabletCancelled Post Market
02265583BCI METFORMINBAKER CUMMINS INC850 MGTabletCancelled Post Market
02265575BCI METFORMINBAKER CUMMINS INC500 MGTabletCancelled Post Market
02564270BIO-METFORMINBIOMED PHARMA850 MGTabletApproved
02564262BIO-METFORMINBIOMED PHARMA500 MGTabletApproved
02449331BIO-METFORMINBIOMED PHARMA850 MGTabletCancelled Pre Market
02449323BIO-METFORMINBIOMED PHARMA500 MGTabletCancelled Pre Market
02242726DOM-METFORMINDOMINION PHARMACAL850 MGTabletCancelled Post Market
02229994DOM-METFORMINDOMINION PHARMACAL500 MGTabletCancelled Post Market
02421836ECL-METFORMINECL PHARMA GROUP LTD850 MGTabletCancelled (Unreturned Annual)
02421828ECL-METFORMINECL PHARMA GROUP LTD500 MGTabletCancelled (Unreturned Annual)
02572273GLN-METFORMIN XRGLENMARK PHARMACEUTICALS CANADA INC.1000 MGTablet (Extended-Release)Approved
02162849GLUCOPHAGESANOFI-AVENTIS CANADA INC850 MGTabletCancelled Post Market
02099233GLUCOPHAGESANOFI-AVENTIS CANADA INC500 MGTabletMarketed
02446065GLUCOPHAGESANOFI-AVENTIS CANADA INC1000 MGTabletCancelled Pre Market
02300451GLUMETZABAUSCH HEALTH, CANADA INC.1000 MGTablet (Extended-Release)Marketed
02268493GLUMETZABAUSCH HEALTH, CANADA INC.500 MGTablet (Extended-Release)Marketed
02268507GLUMETZA (SB)BAUSCH HEALTH, CANADA INC.1000 MGTablet (Extended-Release)Approved
02239214GLYCONBAUSCH HEALTH, CANADA INC.850 MGTabletDormant
02229516GLYCONBAUSCH HEALTH, CANADA INC.500 MGTabletDormant
02463601GPC-METFORMIN XRSTRIDES PHARMA CANADA INC500 MGTablet (Extended-Release)Approved
02463628GPC-METFORMIN XRSTRIDES PHARMA CANADA INC1000 MGTablet (Extended-Release)Approved
02455420INVOKAMETJANSSEN INC50 MGTabletMarketed
02455447INVOKAMETJANSSEN INC150 MGTabletCancelled Post Market
02455455INVOKAMETJANSSEN INC150 MGTabletMarketed
02455404INVOKAMETJANSSEN INC50 MGTabletMarketed
02455439INVOKAMETJANSSEN INC150 MGTabletCancelled Post Market
02455412INVOKAMETJANSSEN INC50 MGTabletCancelled Post Market
02477424INVOKAMET XRJANSSEN INC150 MGTablet (Extended-Release)Cancelled Pre Market
02477408INVOKAMET XRJANSSEN INC50 MGTablet (Extended-Release)Cancelled Pre Market
02477394INVOKAMET XRJANSSEN INC50 MGTablet (Extended-Release)Cancelled Pre Market
02477416INVOKAMET XRJANSSEN INC150 MGTablet (Extended-Release)Cancelled Pre Market
02378051IPG-METFORMINMARCAN PHARMACEUTICALS INC850 MGTabletApproved
02378043IPG-METFORMINMARCAN PHARMACEUTICALS INC500 MGTabletApproved
02380196JAMP METFORMINJAMP PHARMA CORPORATION500 MGTabletMarketed
02380218JAMP METFORMINJAMP PHARMA CORPORATION850 MGTabletMarketed
02556200JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMINJAMP PHARMA CORPORATION50 MGTabletMarketed
02556189JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMINJAMP PHARMA CORPORATION50 MGTabletMarketed
02556197JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMINJAMP PHARMA CORPORATION50 MGTabletMarketed
02380730JAMP-METFORMIN BLACKBERRYJAMP PHARMA CORPORATION850 MGTabletCancelled Post Market
02380722JAMP-METFORMIN BLACKBERRYJAMP PHARMA CORPORATION500 MGTabletCancelled Post Market
02333856JANUMETMERCK CANADA INC50 MGTabletMarketed
02333872JANUMETMERCK CANADA INC50 MGTabletMarketed
02333864JANUMETMERCK CANADA INC50 MGTabletCancelled Post Market
02416808JANUMET XRMERCK CANADA INC100 MGTablet (Extended-Release)Marketed
02416794JANUMET XRMERCK CANADA INC50 MGTablet (Extended-Release)Marketed
02416786JANUMET XRMERCK CANADA INC50 MGTablet (Extended-Release)Marketed
02403269JENTADUETOBOEHRINGER INGELHEIM (CANADA) LTD LTEE2.5 MGTabletMarketed
02403250JENTADUETOBOEHRINGER INGELHEIM (CANADA) LTD LTEE500 MGTabletMarketed
02403277JENTADUETOBOEHRINGER INGELHEIM (CANADA) LTD LTEE2.5 MGTabletMarketed
02417235KAZANOTAKEDA CANADA INC12.5 MGTabletMarketed
02417219KAZANOTAKEDA CANADA INC12.5 MGTabletMarketed
02417227KAZANOTAKEDA CANADA INC12.5 MGTabletMarketed
02389177KOMBOGLYZEASTRAZENECA CANADA INC2.5 MGTabletCancelled Post Market
02389169KOMBOGLYZEASTRAZENECA CANADA INC2.5 MGTabletCancelled Post Market
02389185KOMBOGLYZEASTRAZENECA CANADA INC2.5 MGTabletCancelled Post Market
02547767M-METFORMINMANTRA PHARMA INC500 MGTabletMarketed
02548275M-METFORMINMANTRA PHARMA INC1000 MGTabletMarketed
02547775M-METFORMINMANTRA PHARMA INC850 MGTabletMarketed
02551853M-METFORMIN XRMANTRA PHARMA INC1000 MGTablet (Extended-Release)Marketed
02551845M-METFORMIN XRMANTRA PHARMA INC500 MGTablet (Extended-Release)Marketed
02570602M-SITAGLIPTIN-METFORMINMANTRA PHARMA INC50 MGTabletApproved
02570629M-SITAGLIPTIN-METFORMINMANTRA PHARMA INC50 MGTabletApproved
02570610M-SITAGLIPTIN-METFORMINMANTRA PHARMA INC50 MGTabletApproved

Sourcing Metformin Hydrochloride through a licensed wholesaler

Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Metformin Hydrochloride we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.

Request a quote

Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Metformin Hydrochloride and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.

Request a sourcing quote or call +1 (431) 588-9055.

Related pages